立達信(605365.SH):擬以3000萬元認購私募基金份額
格隆匯12月28日丨立達信(605365.SH)公佈,2021年12月27日,公司全資子公司廈門立人投資有限公司(“立人投資”)簽署了《廈門堅果矽力創業投資合夥企業(有限合夥)合夥協議》,立人投資作為有限合夥人在標的基金中認繳出資人民幣3000萬元,佔基金13.0208%的份額。
主要投資領域:以信息技術驅動的新生產、新消費、新服務的科技創新類項目。其中投資於跨境出海方向或可能朝跨境出海方向發展的項目金額不低於基金可投金額(即基金扣除管理費等各項費用後可用於投資的款項)的 80%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.